Intra-abdominal Infection
📧 Sign up to get email alerts when something new happens for Intra-abdominal Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-07FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application from B. Braun Medical Inc. for Cefepime hydrochloride and dextrose, adding this formulation under th…
-
FDA approval · 2026-03-11FDA Approved: MEROPENEM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Meropenem by Sandoz Inc, resulting in updated regulatory status for the product.
-
FDA approval · 2025-06-23FDA Approved: MEROPENEM — Original Application (BROOKS STERISCIENCE LIMITED)
FDA approved the original application for a generic meropenem product manufactured by Brooks SterisScience Limited.
-
FDA approval · 2024-10-25FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
FDA approval · 2024-08-22FDA Approved: AMPICILLIN AND SULBACTAM — Supplemental Application (Eugia US LLC)
FDA granted supplemental approval for Ampicillin and Sulbactam (AMPICILLIN AND SULBACTAM) submitted by Eugia US LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-07-22FDA Approved: MEROPENEM — Original Application (Qilu Antibiotics Pharmaceutical Co., Ltd.)
FDA approved the original application for Meropenem from Qilu Antibiotics Pharmaceutical Co., Ltd., authorizing sale of a generic Meropenem …
-
FDA approval · 2024-06-24FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium by Sandoz Inc to support changes to the approved gener…
-
FDA approval · 2024-06-18FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals Inc. (d/b/a Avet Pharmaceuticals Inc.) to modify…
-
FDA approval · 2024-05-01FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Civica, Inc. for Piperacillin and Tazobactam (piperacillin/tazobactam).
-
FDA approval · 2024-04-25FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a Supplemental Application for Amoxicillin and clavulanate potassium by NorthStar Rx LLC, indicating a modification to an exist…
-
FDA approval · 2022-03-18FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Cefepime hydrochloride and dextrose from B. Braun Medical Inc.
-
FDA approval · 2022-03-16FDA Approved: METRONIDAZOLE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for METRONIDAZOLE submitted by Prasco Laboratories.
-
FDA approval · 2021-08-19FDA Approved: METRONIDAZOLE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for METRONIDAZOLE submitted by Unichem Pharmaceuticals (USA), Inc., signaling an approved change…
-
FDA approval · 2021-04-16FDA Approved: AZACTAM — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for AZACTAM (aztreonam) from E.R. Squibb & Sons, L.L.C. The approval updates the product labeling fo…
-
FDA approval · 2021-03-05FDA Approved: METRONIDAZOLE — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Metronidazole submitted by Baxter Healthcare Corporation.
-
FDA approval · 2021-02-16FDA Approved: PIPERACILLIN, TAZOBACTAM — Original Application (Sagent Pharmaceuticals)
FDA approves Sagent Pharmaceuticals' generic Piperacillin-tazobactam for intravenous use under Original Application, enabling a generic vers…
-
FDA approval · 2020-09-09FDA Approved: CEFTRIAXONE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Ceftriaxone and Dextrose from B. Braun Medical, resulting in an updated/expanded approval for th…
-
FDA approval · 2020-08-03FDA Approved: METRONIDAZOLE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic metronidazole (ANDA 212435), enabling a generic version of metronidazole for its establi…
-
FDA approval · 2020-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and clavulanate potassium by Sandoz Inc.
-
FDA approval · 2019-08-16FDA Approved: MEROPENEM — Original Application (WG Critical Care, LLC)
FDA approved WG Critical Care, LLC's original ANDA for Meropenem, providing a generic version of the carbapenem antibiotic.
-
FDA approval · 2019-07-29FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Metronidazole from Aurobindo Pharma Limited, updating an existing generic product approval.
-
FDA approval · 2019-02-25FDA Approved: METRONIDAZOLE — Original Application (Hospira, Inc.)
FDA approves Hospira's original application for metronidazole (generic) for use in several anaerobic bacterial infections and protozoal infe…
-
FDA approval · 2018-06-25FDA Approved: ERTAPENEM — Original Application (Eugia US LLC)
The FDA approved an original application for ertapenem from Eugia US LLC, authorizing a generic version of the carbapenem antibiotic ertapen…
-
FDA approval · 2018-04-03FDA Approved: FLAGYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Flagyl (metronidazole) from Pfizer Laboratories Div Pfizer Inc, resulting in changes to the …
-
FDA approval · 2017-12-12FDA Approved: METRONIDAZOLE — Original Application (Cadila Pharmaceuticals Limited)
FDA approved Cadila Pharmaceuticals' generic metronidazole under an Original Application (ANDA209794).